EMR Quantitative Stock Analysis

Validea's guru fundamental report indicates that Emerson Electric (EMR) scores favorably (68%) under their Multi-Factor Investor model, which is based on the strategy of Pim van Vliet and favors low volatility stocks with strong momentum and high net payout yields; however, a score of 80% or higher is needed to indicate interest in the stock.

Analysis

Emerson Electric Co. (EMR), a large-cap growth stock within the Scientific & Technical Instruments industry, has been evaluated by Validea's guru fundamental report, specifically using the Multi-Factor Investor model based on Pim van Vliet's strategy. This model prioritizes low volatility stocks that concurrently exhibit strong momentum and high net payout yields. EMR achieved a rating of 68% under this strategy, a score which is below the 80% threshold that typically signals strategy interest, and significantly below the 90% mark for strong interest. While EMR passed the model's tests for Market Cap and Standard Deviation, indicating favorable low-volatility characteristics, it received neutral assessments for "Twelve Minus One Momentum" and "Net Payout Yield." Consequently, EMR received a "FAIL" on its "Final Rank" according to this specific strategy's criteria. The moderately negative sentiment score of -0.45 associated with EMR reflects this suboptimal quantitative screening, highlighting that despite its low volatility profile, its current momentum and yield metrics do not meet the specific requirements of the van Vliet model.

Key Decisions for Investors

• Investors adhering to Pim van Vliet's multi-factor strategy should be aware that EMR's 68% score and 'FAIL' on the final rank indicate it does not currently meet the criteria for inclusion based on this specific approach.
• While EMR demonstrates favorable low volatility attributes, its neutral ratings on momentum and net payout yield are significant limiting factors under this particular investment model, warranting caution for those prioritizing these combined factors.
• Consider monitoring EMR for potential improvements in its momentum and net payout yield metrics if seeking alignment with conservative factor investing strategies that emphasize these elements alongside low volatility.